Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Brain Trauma Disrupts Hepatic Lipid Metabolism: Blame It on Fructose?

Rege SD, Royes L, Tsai B, Zhang G, Yang X, Gomez-Pinilla F.

Mol Nutr Food Res. 2019 Aug;63(15):e1801054. doi: 10.1002/mnfr.201801054. Epub 2019 Jun 6.

PMID:
31087499
2.

Can Diet and Physical Activity Limit Alzheimer's Disease Risk?

Rege SD, Geetha T, Broderick TL, Babu JR.

Curr Alzheimer Res. 2017;14(1):76-93. Review.

PMID:
26971938
3.

Resveratrol protects β amyloid-induced oxidative damage and memory associated proteins in H19-7 hippocampal neuronal cells.

Rege SD, Geetha T, Broderick TL, Babu JR.

Curr Alzheimer Res. 2015;12(2):147-56.

PMID:
25654502
4.

Mg2+/Mn2+-dependent phosphatase 1A is involved in regulating pregnane X receptor-mediated cytochrome p450 3A4 gene expression.

Pondugula SR, Flannery PC, Apte U, Babu JR, Geetha T, Rege SD, Chen T, Abbott KL.

Drug Metab Dispos. 2015 Mar;43(3):385-91. doi: 10.1124/dmd.114.062083. Epub 2015 Jan 5.

PMID:
25561723
5.

Neuroprotective effects of resveratrol in Alzheimer disease pathology.

Rege SD, Geetha T, Griffin GD, Broderick TL, Babu JR.

Front Aging Neurosci. 2014 Sep 11;6:218. doi: 10.3389/fnagi.2014.00218. eCollection 2014. Review.

6.

Resveratrol protects the brain of obese mice from oxidative damage.

Rege SD, Kumar S, Wilson DN, Tamura L, Geetha T, Mathews ST, Huggins KW, Broderick TL, Babu JR.

Oxid Med Cell Longev. 2013;2013:419092. doi: 10.1155/2013/419092. Epub 2013 Sep 15.

7.

Nerve growth factor receptor TrkA, a new receptor in insulin signaling pathway in PC12 cells.

Geetha T, Rege SD, Mathews SE, Meakin SO, White MF, Babu JR.

J Biol Chem. 2013 Aug 16;288(33):23807-13. doi: 10.1074/jbc.M112.436279. Epub 2013 Jun 7.

8.

Noncoding RNAs in Neurodegenerative Diseases.

Rege SD, Geetha T, Pondugula SR, Zizza CA, Wernette CM, Babu JR.

ISRN Neurol. 2013 Apr 30;2013:375852. doi: 10.1155/2013/375852. Print 2013.

9.

Development of a dot-blot assay for screening monoclonal antibodies to low-molecular-mass drugs.

Rupprecht KR, Nair RK, Harwick LC, Grote J, Beligere GS, Rege SD, Chen YY, Lin Z, Fishpaugh JR.

Anal Biochem. 2010 Dec 15;407(2):160-4. doi: 10.1016/j.ab.2010.08.003. Epub 2010 Aug 7.

PMID:
20696124
10.

An efficient synthesis of a heterobifunctional coupling agent.

Reddy RE, Chen YY, Johnson DD, Beligere GS, Rege SD, Pan Y, Thottathil JK.

Bioconjug Chem. 2005 Sep-Oct;16(5):1323-8.

PMID:
16173814
11.

Binding interactions of vancomycin tracers with a bacterial cell wall peptidoglycan analogue.

Adamczyk M, Grote J, Moore JA, Rege SD, Yu Z.

Bioorg Med Chem Lett. 2000 Jul 17;10(14):1613-5.

PMID:
10915064
12.

Investigations into self-association of vancomycin covalent dimers using surface plasmon resonance technology.

Adamczyk M, Moore JA, Rege SD, Yu Z.

Bioorg Med Chem Lett. 1999 Aug 16;9(16):2437-40.

PMID:
10476883
13.
14.

Development of a quantitative vancomycin immunoassay for the Abbott AxSYM analyzer.

Adamczyk M, Brate EM, Chiappetta EG, Ginsburg S, Hoffman E, Klein C, Perkowitz MM, Rege SD, Chou PP, Costantino AG.

Ther Drug Monit. 1998 Apr;20(2):191-201.

PMID:
9558134
15.

Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET.

Rege SD, Chaiken L, Hoh CK, Choi Y, Lufkin R, Anzai Y, Juillard G, Maddahi J, Phelps ME, Hawkins RA.

Radiology. 1993 Dec;189(3):807-12.

PMID:
8234708
16.

Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.

Rege SD, Hoh CK, Glaspy JA, Aberle DR, Dahlbom M, Razavi MK, Phelps ME, Hawkins RA.

Cancer. 1993 Jul 1;72(1):82-90.

PMID:
8389668
17.

Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation.

Jabour BA, Choi Y, Hoh CK, Rege SD, Soong JC, Lufkin RB, Hanafee WN, Maddahi J, Chaiken L, Bailet J, et al.

Radiology. 1993 Jan;186(1):27-35.

PMID:
8416578

Supplemental Content

Support Center